These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3625704)

  • 21. Derivatives of cis-2-amino-8-hydroxy-1-methyltetralin: mixed 5-HT1A-receptor agonists and dopamine D2-receptor antagonists.
    Liu Y; Yu H; Mohell N; Nordvall G; Lewander T; Hacksell U
    J Med Chem; 1995 Jan; 38(1):150-60. PubMed ID: 7530773
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin.
    Johansson AM; Fredriksson K; Hacksell U; Grol CJ; Svensson K; Carlsson A; Sundell S
    J Med Chem; 1990 Oct; 33(10):2925-9. PubMed ID: 2120444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors.
    Wikström H; Andersson B; Elebring T; Svensson K; Carlsson A; Largent B
    J Med Chem; 1987 Dec; 30(12):2169-74. PubMed ID: 2824773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dopaminergic 2-aminotetralins: affinities for dopamine D2-receptors, molecular structures, and conformational preferences.
    Johansson AM; Karlén A; Grol CJ; Sundell S; Kenne L; Hacksell U
    Mol Pharmacol; 1986 Sep; 30(3):258-69. PubMed ID: 2943981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacology of the enantiomers of UH301: opposing interactions with 5-HT1A receptors.
    Hillver SE; Björk L; Höök BB; Cortizo L; Nordvall G; Johansson AM; Ertan A; Csöregh I; Johansson L; Lewander T; Hacksell U
    Chirality; 1996; 8(8):531-44. PubMed ID: 9025253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in the stereochemistry of the kappa-selective opioid agonist U50,488 result in high-affinity sigma ligands.
    de Costa BR; Bowen WD; Hellewell SB; George C; Rothman RB; Reid AA; Walker JM; Jacobson AE; Rice KC
    J Med Chem; 1989 Aug; 32(8):1996-2002. PubMed ID: 2547074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and serotonin binding site studies of some conformationally restricted indolylethylamine analogues based on 2-amino-3-(3'-indolyl)bicyclo[2.2.2]octane.
    Schlecht MF; Tsarouhtsis D; Lipovac MN; Debler EA
    J Med Chem; 1990 Jan; 33(1):386-94. PubMed ID: 2136918
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cis- and trans-4-n-Propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolines.
    Cannon JG; Koble-Suarez C; Long JP; Ilhan M; Bhatnagar RK
    J Pharm Sci; 1985 Jun; 74(6):672-5. PubMed ID: 4040568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orally active central dopamine and serotonin receptor ligands: 5-, 6-, 7-, and 8-[[trifluoromethyl)sulfonyl]oxy]-2-(di-n-propylamino)tetralins and the formation of active metabolites in vivo.
    Sonesson C; Boije M; Svensson K; Ekman A; Carlsson A; Romero AG; Martin IJ; Duncan JN; King LJ; Wikström H
    J Med Chem; 1993 Oct; 36(22):3409-16. PubMed ID: 8230131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N,N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin.
    Glennon RA; Titeler M; Lyon RA; Slusher RM
    J Med Chem; 1988 Apr; 31(4):867-70. PubMed ID: 2965244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the preferred rotameric conformation for dopamine agonist action: an illusory quest.
    Costall B; Lim SK; Naylor RJ; Cannon JG
    J Pharm Pharmacol; 1982 Apr; 34(4):246-54. PubMed ID: 6124599
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Centrally acting serotonergic and dopaminergic agents. 2. Synthesis and structure-activity relationships of 2,3,3a,4,9,9a-hexahydro-1H-benz[f]indole derivatives.
    Lin CH; Haadsma-Svensson SR; Phillips G; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
    J Med Chem; 1993 Apr; 36(8):1069-83. PubMed ID: 8097538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivatives.
    Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; Von Voigtlander PF; Smith MW; Chidester CG
    J Med Chem; 1993 Apr; 36(8):1053-68. PubMed ID: 8097537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N,N-Dialkylated monophenolic trans-2-phenylcyclopropylamines: novel central 5-hydroxytryptamine receptor agonists.
    Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Lindberg P; Andersson B
    J Med Chem; 1988 Jan; 31(1):92-9. PubMed ID: 3336037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Centrally acting serotonergic agents. Synthesis and structure-activity relationships of C-1- or C-3-substituted derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; VonVoigtlander PF; Chidester CG
    J Med Chem; 1993 Mar; 36(6):671-82. PubMed ID: 8459396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase.
    Cornfield LJ; Lambert G; Arvidsson LE; Mellin C; Vallgårda J; Hacksell U; Nelson DL
    Mol Pharmacol; 1991 Jun; 39(6):780-7. PubMed ID: 1828859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
    Björk L; Höök BB; Nelson DL; Andén NE; Hacksell U
    J Med Chem; 1989 Apr; 32(4):779-83. PubMed ID: 2522991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation.
    Johansson AM; Nilsson JL; Karlén A; Hacksell U; Svensson K; Carlsson A; Kenne L; Sundell S
    J Med Chem; 1987 Jul; 30(7):1135-44. PubMed ID: 3599021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine receptor stimulating and alpha adrenoceptor blocking actions of trans (CS-265) and cis (CS-263) isomers of nonhydroxylated N-propyl octahydrobenzo[F]quinoline.
    Ilhan M; Long JP; Cannon JG
    J Pharmacol Exp Ther; 1984 Nov; 231(2):361-6. PubMed ID: 6149308
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.